Delivery Order SPE2DB20D3304-SPE2DB26FW4N5
- Not listed
- The Defense Logistics Agency (DLA) awarded a $1,360.45 delivery order to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 mL pens on July 22, 2025, with completion expected by July 23, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order fulfilling pharmaceutical supply needs for federal medical procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a $1,088.36 delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pen medication on July 25, 2025, with completion targeted for July 28, 2025. This firm fixed-price contract represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded a delivery order valued at $3,392.79 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 mL pens on August 15, 2025, with completion expected by August 18, 2025. This firm fixed price, non-set-aside delivery order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's critical role as a pharmaceutical distributor supporting federal medical procurement needs,...
- The Defense Logistics Agency awarded a $5,268.40 delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen medication on November 4, 2025, with completion scheduled for November 5, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $41,938.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens. This is a non-set-aside competitive award with a completion date of November 4, 2025, with performance to be completed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,078.40 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 mL pens on November 5, 2025, with an ultimate completion date of November 6, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was awarded through open competition. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a $10,538.63 firm fixed price delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 mL pens on July 2, 2025, with completion scheduled for July 3, 2025. This non-set-aside award represents a routine pharmaceutical procurement to support federal medical supply needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $7,755.60 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 ml pens on August 7, 2025, with completion targeted for August 8, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The product will be supplied to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,586.22 to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens (0.5 mL). This firm fixed-price delivery order is non-competitive and utilizes a competitively awarded indefinite delivery contract vehicle. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025. As a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Mounjaro 12.5 mg/0.5 mL pens with a ceiling value of $1,317.10. This non-set-aside, firm fixed-price delivery order is scheduled for completion by November 10, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The product delivery supports the military and federal healthcare supply chain, consistent with the...
- SPE2DB20D3304Indefinite Delivery Contract
- SPE2DB20D3304-SPE2DB26FW4N5Delivery Order
The Defense Logistics Agency awarded a $1,550.97 firm fixed price delivery order to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 ml pen medication on November 10, 2025, with completion targeted for November 12, 2025. This non-set-aside competitive award represents a pharmaceutical supply delivery to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and veteran healthcare systems through the DLA's medical supply chain. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a one billion dollar ceiling and runs through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 11/10/25 |